Send me a link:

*Text messaging rates may apply.

 Dow Down1.88% Nasdaq Down2.09%

Calypte Biomedical Corp. (CBMC)

-Other OTC
0.01 0.00(0.00%) 3:22PM EDT
ProfileGet Profile for:
Calypte Biomedical Corp.
15875 SW 72nd Avenue
Portland, OR 97224
United States - Map
Phone: 503-726-2227
Fax: 503-601-6299

Index Membership:N/A
Full Time Employees:3

Business Summary 

Calypte Biomedical Corporation develops, manufactures, and distributes in vitro diagnostic tests primarily for the diagnosis of human immunodeficiency virus (HIV) infection in the United States. The company focuses on the commercialization of HIV-1/2 Rapid Tests, test products for the rapid detection of antibodies to HIV-1 and HIV Type 2 in oral fluid using a lateral flow dipstick design. Its products also comprise Aware HIV-1/2 OMT test to address the drawbacks of blood testing; and Aware HIV-1/2 Oral OTC test, which is an over-the-counter version of oral fluid rapid test. In addition, the company provides Aware BED HIV-1 Incidence Test that is used to estimate the rate of new HIV infections in populations by determining the proportion of a population of HIV-infected individuals within approximately the prior six months of sample collection, and could be used by public health agencies to identify those regions and the populations within them where HIV transmission is occurring most recently. Further, it offers Aware Messenger, an oral fluid collection device, which is intended for the collection, stabilization, and transport of an oral fluid specimen to be used for the detection of specific antibodies or other substances. Additionally, it intends to provide Aware 2 line, a rapid testing solution with cassette-enclosed format. The company sells its products through local distributors in the domestic market; and products primarily in Africa and the Middle East. Calypte Biomedical Corporation was founded in 1988 and is headquartered in Portland, Oregon.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Calypte Biomedical Corp.

Key Executives 
Mr. Adel Karas , 68
Chairman, Chief Exec. Officer, Pres and Member of Nominating Committee
Mr. Kartlos Edilashvili , 40
Chief Financial Officer, Principal Accounting Officer, VP, Sec. and Director
Mr. J. Daniel Clark , 68
VP of Sales and Marketing
Ms. Khatuna Janjalia ,
Pres of Geneva Branch Office
Mr. Ravi Pandit ,
Amounts are as of Dec 31, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.